Disclosure Of Interests In Other Entities [Text Block]

GENFLOW BIOSCIENCES PLC - Filing #5893549

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]		—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	—	—	—	383,841 GBP	—	—	—	—	1,068,259 GBP	—	—	—	—
Non-current assets	—	—	—	2,067 GBP	—	—	—	—	3,394 GBP	—	—	—	—
Profit (loss)	1,587,235 GBP	- GBP	- GBP	—	- GBP	1,587,235 GBP	- GBP	1,860,345 GBP	—	- GBP	1,860,345 GBP	- GBP	—
Comprehensive income	1,566,301 GBP	- GBP	- GBP	—	20,934 GBP	1,587,235 GBP	- GBP	1,866,780 GBP	—	- GBP	1,860,345 GBP	6,435 GBP	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Profit (loss) from continuing operations	1,587,235 GBP	—	—	—	—	—	—	1,860,345 GBP	—	—	—	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	—	278,682 GBP	—	—	—	—	683,974 GBP	—	—	—	2,356,225 GBP
Tax expense (income)	- GBP	—	—	—	—	—	—	- GBP	—	—	—	—	—